Adamas Pharmaceuticals, Inc.

Rowan Chapman

Timothy J Fultz

Gregory T Went

Terry L Burkoth

David Chernoff

Mickey S Urdea

Jack Nguyen

Paul Spence

Kits comprising an M2 inhibitor selected from amantadine and rimantadine; ribavirin, and a neuraminidase inhibitor (NAi) in an amount that is antivirally effective in the combination, an oral dosage form containing 75-250 mg of the M2 inhibitor, an oral dosage form comprising 100-400 mg of ribavirin and a neuraminidase inhibitor are provided for the treatment of influenza. Some embodiments of the kits comprise an oral dosage form containing 75-250 mg of the M2 inhibitor, an oral dosage form comprising 100-400 mg of ribavirin, and a neuraminidase inhibitor.

Compositions and kits for treating influenza

Compositions, kits and methods are provided for the treatment or prophylaxis of influenza.

Growing community of inventors

Burlingame, CA, United States of America

Rowan Chapman